← All beauty signals
Wellness turn

The Measured Regimen

Devices that read skin and recommend a routine sit on shop counters and in labs. Dispensing the treatment rests on CES demonstrations, after P&G shut its Opté wand in 2023.

What is it?

A device that scans skin and recommends a routine is real and growing; one that scans skin and physically dispenses a treatment is not. La Roche-Posay and an MIT-Amorepacific prototype both recommend from a scan; the one dispensing precedent, P&G’s Opté wand, was discontinued in 2023.

Why now?

2026 brought the clearest independent look yet at the recommend-only category: Skinsight debuted at CES as a research-stage patch that explicitly does not dispense. That sharpens a distinction brands often blur — a device that reads skin and suggests a product is proven; one that makes the product is not.

Who’s building it?

Beauty brands and researchers build scan-and-recommend tools; no shipping device yet scans and dispenses a bespoke treatment.

La Roche-PosayMITAmorepacificP&G VenturesSkinive
The full read
Why now, who is building it, where the market goes, and what stays unsettled.
Get weekly →
01 · The market
Who’s in it
Brands — La Roche-Posay and Amorepacific, both building scan-and-recommend tools.
Researchers — MIT, building a pre-commercial patch that reads but does not dispense.
Regulators — the agencies who would classify a device the moment it starts dispensing.
What’s at stake
Whether a shipping device ever again scans and dispenses a bespoke treatment the way Opté once tried to.
Recommendation tools keep launching and shipping across several beauty brands.
The dispensing category has no live product at all.
What’s unsettled
Whether Opté failed for a technical reason or a business one.
Whether Skinsight or a rival ever reaches a shipping product.
Whether any brand will attempt physical dispensing again after Opté’s 2023 shutdown.
02 · How the demand matureda progression, not a timeline
Scan
A device or app reads the skin from a photo or sensor.
Recommend
An algorithm matches the read to existing packaged products in a routine.
Prototype
A research device adds sensing but still stops well short of ever dispensing anything itself.
Precedent
The one device that tried to dispense as well was discontinued in 2023.
03 · Where the market goesthe forks, not a prediction
→Whether Skinsight or a similar prototype ever ships as a consumer product, the first recommend-only device to reach real scale.
→Whether any company tries physical dispensing again, given Opté’s discontinued decade of development.
→Whether recommendation tools keep drifting toward a diagnostic claim without ever quite becoming one.
→Whether a bespoke dispensing product ever proves commercially viable at all.
Reading the skin and recommending a routine is proven and growing; reading the skin and dispensing one is a discontinued precedent, not a current product.
04 · The Reads-vs-Dispenses deskrecommend is real, dispense is not
The Brand’s Own Claim
A skin reading, then a routine, brand says.
Lancôme’s Cell BioPrint reads skin proteins and recommends a routine, Glossy reports.
Glossy
The Prototype That Says No
Recommends, and the reporting says so plainly.
Skinsight doesn’t diagnose or automatically dispense, reporting states.
Engadget
The Discontinued Precedent
The one wand that dispensed, shut down.
Opté’s refills ceased in 2023, after over 40 patents.
BeautyMatter
05 · The Wire
01
MIT and Amorepacific built Skinsight, a patch that recommends routines.
Engadget ↗
02
Lancôme’s Cell BioPrint reads skin proteins and recommends a routine
Glossy ↗
03
P&G discontinued its Opté wand, the clearest precedent for a device that scanned skin and physically dispensed a bespoke treatment, in 2023.
BeautyMatter ↗
04
CES 2026 showed systems that read skin, then make or dispense products
Premium Beauty News ↗
The panel on this signal
They agreed on
–Scan-and-recommend devices are a real, evidenced, growing category across multiple brands and independent research groups alike.
–No shipping device currently both scans and physically dispenses.
–Opté remains the clearest precedent for dispensing, and it was discontinued in 2023.
The cosmetic-device commercialization strategist disagreed on
–Opté’s shutdown reads as a technology failure, but the harder problem was a subscription hardware model shoppers weren’t used to buying.
Know more about the method →
✦How this signal was built
01 · Panel
A Delphi panel of 4 AI analysts, each reasoning independently.
→
02 · Debate
They challenge and revise each other’s reads over two rounds.
→
03 · Evidence
Every claim is tied to a cited, linked source on The Wire.
→
04 · Synthesis
A moderator writes it into one read, disagreement and all.
✦Signal changelogre-read as evidence changed
2025
Devices that read skin and recommend a routine exist; devices that read skin and dispense treatment do not, beyond P&G’s Opté, discontinued in 2023.
→
2026
CES 2026 exhibitors showed devices that read skin and make or dispense a matched product, such as Cosmax’s MaXpace; shipping status is not reported. Premium Beauty News ↗